Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 55526 - 55550 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Ozagrel	Investigational	TNFSF11	8600	downregulated	ozagrel results in decreased expression of TNFSF11 mRNA	13q14	A23536
Ozone	Investigational	AHR	196	upregulated	Ozone results in increased expression of AHR mRNA	7p21.1	A23537
Ozone	Investigational	BRS3	680	upregulated	Ozone results in increased expression of BRS3 mRNA	Xq26.3	A23538 A23539
Ozone	Investigational	CFTR	1080	downregulated	Ozone results in decreased expression of CFTR mRNA	7q31.2	A23540
Ozone	Investigational	COL1A1	1277	upregulated	Ozone results in increased expression of COL1A1 mRNA	17q21.33	A23541
Ozone	Investigational	COL3A1	1281	upregulated	Ozone results in increased expression of COL3A1 mRNA	2q32.2	A23541
Ozone	Investigational	CXCL8	3576	upregulated	Ozone results in increased expression of CXCL8 mRNA	4q13.3	A23542 A23543 A23544 A23545 A23546 A23547 A23548
Ozone	Investigational	CYP1A1	1543	upregulated	Ozone results in increased expression of CYP1A1 mRNA	15q24.1	A23537
Ozone	Investigational	CYP1A2	1544	upregulated	Ozone results in increased expression of CYP1A2 mRNA	15q24.1	A23537
Ozone	Investigational	CYP1B1	1545	upregulated	Ozone results in increased expression of CYP1B1 mRNA	2p22.2	A23537
Ozone	Investigational	HMOX1	3162	upregulated	Ozone results in increased expression of HMOX1 mRNA	22q12.3	A23546
Ozone	Investigational	IL5	3567	downregulated	Ozone results in decreased expression of IL5 mRNA	5q31.1	A23549
Ozone	Investigational	IL6	3569	upregulated	Ozone results in increased expression of IL6 mRNA	7p15.3	A23542 A23546
Ozone	Investigational	MIR132	406921	upregulated	Ozone results in increased expression of MIR132 mRNA	17p13.3	A23550
Ozone	Investigational	MIR143	406935	upregulated	Ozone results in increased expression of MIR143 mRNA	5q32	A23550
Ozone	Investigational	MIR145	406937	upregulated	Ozone results in increased expression of MIR145 mRNA	5q32	A23550
Ozone	Investigational	MIR199B	406978	upregulated	Ozone results in increased expression of MIR199B mRNA	9q34.11	A23550
Ozone	Investigational	MIR222	407007	upregulated	Ozone results in increased expression of MIR222 mRNA	Xp11.3	A23550
Ozone	Investigational	MIR25	407014	upregulated	Ozone results in increased expression of MIR25 mRNA	7q22.1	A23550
Ozone	Investigational	MIR424	494336	upregulated	Ozone results in increased expression of MIR424 mRNA	Xq26.3	A23550
Ozone	Investigational	MIR582	693167	upregulated	Ozone results in increased expression of MIR582 mRNA	5q12.1	A23550
Ozone	Investigational	PTGS2	5743	upregulated	Ozone results in increased expression of PTGS2 mRNA	1q31.1	A23545 A23546
Ozone	Investigational	TGFB1	7040	upregulated	Ozone results in increased expression of TGFB1 mRNA	19q13.1	A23541
Paclitaxel	Approved Investigational Vet Approved	ABCA5	23461	upregulated	Paclitaxel results in increased expression of ABCA5 mRNA	17q24.3	A22202
Paclitaxel	Approved Investigational Vet Approved	ABCA7	10347	upregulated	Paclitaxel results in increased expression of ABCA7 mRNA	19p13.3	A22202

Displaying entries 55526 - 55550 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability